Assignee
VEGENICS PTY LTD
AU·13 granted patents·13 pending applications·28 citations·filing 2002–2024
Top patents by PatentIndex Score
26 records- 0189US7928061B2Methods of using VEGF-D polypeptidesVEGENICS PTY LTD·Filed 2007·Granted Apr 19, 2011·6 cites·15 claims
- 0288US11209444B2Treatment for age-related macular degeneration (AMD) and pathogenic ocular neovascularizationVEGENICS PTY LTD·Filed 2019·Granted Dec 28, 2021·3 cites·34 claims
- 0387US7902149B2Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteinsVEGENICS PTY LTD·Filed 2009·Granted Mar 8, 2011·7 cites·13 claims
- 0484US2024368248A1Growth factor antagonists for organ transplant alloimmunity and arteriosclerosisVEGENICS PTY LTD·Filed 2024·Application pending·0 cites
- 0580US2024301370A1Ligand Binding Molecules and Uses ThereofVEGENICS PTY LTD·Filed 2023·Application pending·0 cites
- 0673US8025886B2Modified VEGF-A with improved angiogenic propertiesVEGENICS PTY LTD·Filed 2006·Granted Sep 27, 2011·2 cites·48 claims
- 0771US10494617B2Ligand binding molecules and uses thereofVEGENICS PTY LTD·Filed 2017·Granted Dec 3, 2019·1 cites·53 claims
- 0869US11866739B2Ligand binding molecules and uses thereofVEGENICS PTY LTD·Filed 2019·Granted Jan 9, 2024·0 cites·19 claims
- 0968US9745558B2VEGFR-3 ligand binding molecules and uses thereofVEGENICS PTY LTD·Filed 2014·Granted Aug 29, 2017·1 cites·49 claims
- 1068US8383788B2C-Fos induced growth factor (FIGF) and DNA encoding sameVEGENICS PTY LTD·Filed 2002·Granted Feb 26, 2013·8 cites·23 claims
- 1168US2021395339A1Growth factor antagonists for organ transplant alloimmunity and arteriosclerosisVEGENICS PTY LTD·Filed 2021·Application pending·0 cites
- 1268US2022404377A1Treatment for age-related macular degeneration (amd)VEGENICS PTY LTD·Filed 2021·Application pending·0 cites
- 1366US8759286B2Pharmaceutical compositions comprising a VEGF-D polypeptideVEGENICS PTY LTD·Filed 2013·Granted Jun 24, 2014·0 cites·5 claims
- 1465US2015158928A1Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapyVEGENICS PTY LTD·Filed 2014·Application pending·0 cites
- 1564US8637262B2Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereofVEGENICS PTY LTD·Filed 2012·Granted Jan 28, 2014·0 cites·7 claims
- 1661US2014072511A1Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapyVEGENICS PTY LTD·Filed 2013·Application pending·0 cites
- 1760US9260526B2Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapyVEGENICS PTY LTD·Filed 2014·Granted Feb 16, 2016·0 cites·33 claims
- 1860US8357669B2Method of treatment for lymphedema comprising administering a polynucleotide encoding VEGF-DVEGENICS PTY LTD·Filed 2011·Granted Jan 22, 2013·0 cites·20 claims
- 1960US2018118804A1Growth factor antagonists for organ transplant alloimmunity and arteriosclerosisVEGENICS PTY LTD·Filed 2017·Application pending·0 cites
- 2059US9896499B2Growth factor antagonists for organ transplant alloimmunity and arteriosclerosisVEGENICS PTY LTD·Filed 2015·Granted Feb 20, 2018·0 cites·38 claims
- 2158US2016184405A1Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapyVEGENICS PTY LTD·Filed 2015·Application pending·0 cites
- 2256US2025296979A1Pharmaceutical Composition and Method of Using SameVEGENICS PTY LTD·Filed 2023·Application pending·0 cites
- 2348US2013344065A1Combination Treatment with VEGF-C AntagonistsVEGENICS PTY LTD·Filed 2013·Application pending·0 cites
- 2447US2016200793A1Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapyVEGENICS PTY LTD·Filed 2016·Application pending·0 cites
- 2546US2013089551A1Treatment of pulmonary edemaVEGENICS PTY LTD·Filed 2012·Application pending·0 cites
- 2639US2015224191A1Combination Treatment with VEGF-C AntagonistsVEGENICS PTY LTD·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →